ArticleVaccines2025

Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case-Control Study.

Francesca Colavita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.